SPS
AURA icon

Susquehanna Portfolio Strategies’s Aura Biosciences AURA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Sell
28,729
-7,361
-20% -$42.2K ﹤0.01% 908
2025
Q4 		$197K Sell
36,090
-20,708
-36% -$123K ﹤0.01% 952
2025
Q3 		$351K Hold
56,798
– – 0.01% 903
2025
Q2 		$356K Buy
+56,798
New +$332K 0.01% 719

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Susquehanna Portfolio Strategies's AURA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Aura Biosciences (AURA) stake by 20% in Q1 2026, selling an estimated $42.2K and leaving 28,729 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #908.

Susquehanna Portfolio Strategies first reported a position in AURA in Q2 2025 and has held it in 4 quarters since. The position peaked at $356K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Susquehanna Portfolio Strategies held 28,729 shares of Aura Biosciences worth $192K as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 7,361 Aura Biosciences shares in Q1 2026, an estimated $42.2K.
  • Aura Biosciences made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #908 holding.
  • Susquehanna Portfolio Strategies first reported a position in Aura Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Aura Biosciences position peaked at $356K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.